Bill > HF1271

This bill modifies regulations surrounding the sale of cannabinoids derived from hemp in Minnesota, focusing on several key areas of oversight. The legislation updates requirements for selling hemp-derived products, including edible and topical cannabinoid items, establishing stricter guidelines for manufacturing, labeling, and sale. Specifically, the bill mandates that cannabinoid products cannot contain more than 0.3 percent tetrahydrocannabinol, must not be sold to individuals under 21, and requires detailed labeling including manufacturer information, cannabinoid content, and a disclaimer about FDA evaluation. The bill also introduces new provisions for lower-potency hemp edible manufacturers, requiring compliance with building, fire, and zoning codes, and ensuring manufacturing premises are clean and pest-free. Additionally, the legislation clarifies permissible methods of product consumption, prohibiting sales of products intended for vaping or combustion, and establishes standards for on-site consumption of cannabinoid products in licensed retail settings. These changes aim to create a more regulated and safe environment for the sale and consumption of hemp-derived cannabinoid products in Minnesota.

Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF1271&ssn=0&y=2025